Extended hepatic metastasectomy for renal cell carcinoma—new aspects in times of targeted therapy: a single-center experience over three decades

PURPOSE: Despite the introduction of novel targeted therapies on patients with renal cell carcinoma, syn- and metachronous metastases (including hepatic lesions) are observed frequently and significantly influence patient survival. With introduction of targeted therapies as an effective alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Beetz, Oliver, Söffker, Rabea, Cammann, Sebastian, Oldhafer, Felix, Vondran, Florian W. R., Imkamp, Florian, Klempnauer, Jürgen, Kleine, Moritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036059/
https://www.ncbi.nlm.nih.gov/pubmed/31938833
http://dx.doi.org/10.1007/s00423-019-01852-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036059/
https://www.ncbi.nlm.nih.gov/pubmed/31938833
http://dx.doi.org/10.1007/s00423-019-01852-4

Ejemplares similares